finasteride
Chemical compound
Also known as MK 906 · MK-906 · MK906 · (5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
- Formula
- C₂₃H₃₆N₂O₂
1
- C₂₃H₃₆N₂O₂
- Mass
- 372.278 Da
1
- 372.278 Da
Overview
Chemistry
All data
82 statements · 54% with external sources · numbers in brackets are citations
- Medical condition treated
- prostate cancer
1
- bald head
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- prostate disease
1
Sources- 1.Stated in Drug Indications Extracted from FAERSRetrieved 2018-10-02
- prostatic hypertrophy(since 1992) approved by: United States Food and Drug Administration
1
Sources- 1.Stated in Inxight: Drugs Databasedrugs.ncats.io/drug/57GNO57U7GRetrieved 2018-11-02
- Benign Prostatic Hyperplasia
- prostate cancer
- Canonical SMILES
- CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C
1
- CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C
- Isomeric SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
1
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
- Defined daily dose
- 5 milligram route of administration: oral administration
- 1 milligram route of administration: oral administration
- Physically interacts with
- Steroid 5 alpha-reductase 2 subject has role: enzyme inhibitor
1
- Steroid 5 alpha-reductase 2 subject has role: enzyme inhibitor
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
1
Sources- 1.Stated in LiverToxncbi.nlm.nih.gov/books/n/livertox/FinasterideRetrieved 2021-04-08
- LiverTox toxicity likelihood category E
On other databases
45 identifiers linking finasteride across the web's reference databases
- ATC codeG04CB01
- CAS Registry Number98319-26-7
- ChEBI ID5062
- ChEMBL IDCHEMBL710
- ChemSpider ID51714
- DrugBank IDDB01216
- DrugCentral ID1171
- DSSTOX compound identifierDTXCID50625
- DSSTox substance IDDTXSID3020625
- EC number620-534-3
- ECHA Substance Infocard ID100.149.445
- Encyclopædia Britannica Online IDtopic/finasteride
- Freebase ID/m/04lr99
- Guide to Pharmacology Ligand ID6818
- HSDB ID6793
- Human Metabolome Database IDHMDB0001984
- InChIInChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1
- InChIKeyDBEPLOCGEIEOCV-WSBQPABSSA-N
- KBpedia IDFinasteride
- KEGG IDD00321
- LiverTox IDFinasteride
- MassBank accession IDSM858801
- MedlinePlus drug identifiera698016
- MeSH concept IDM0027324
- MeSH descriptor IDD018120
- MeSH tree codeD04.210.500.054.079.500
- Microsoft Academic ID (discontinued)2775874879
- NDF-RT IDN0000148118
- NSC number759318
- OpenAlex IDC2775874879
- PDB ligand IDFIT
- PDB structure ID3G1R
- Probes And Drugs IDPD002995
- PubChem CID57363
- Quora topic IDFinasteride-pharmaceutical
- Reaxys registry number4269024
- RxNorm CUI25025
- SPLASHsplash10-0002-5900000000-3ad6a0d10c51f9892144
- SureChEMBL ID5509
- UK Parliament thesaurus ID507000
- UMLS CUIC0060389
- UniChem compound ID20285
- UNII57GNO57U7G
- UNSPSC code51182001
- WikiProjectMed IDFinasteride